Jury Rules in Favor of Cytek on Majority of Patent Claims
Cytek Biosciences, Inc. prevailed in a Delaware district court jury trial against Beckman Coulter for three of four patent claims regarding assertion of noninfringement and invalidity, though a finding on doctrine of equivalents and a $56M damages award remain.
View filing at SEC.gov →